Royal Philips Electronics has released its upgraded cardiac ultrasound, the iE33 xMATRIX cardiac ultrasound system, which now offers a X5-1 transducer for adult echocardiograms, at the European Society of Cardiology Congress (ESC) this week in Stockholm.
The St. Jude Medical EnSite Cardiac Mapping system, a system used to treat cardiac arrhythmias, is now available for use in Japan.
With the advent of 64-slice CT, coronary CT angiography (CCTA) exams of low-risk patients presenting to the emergency department with chest pain are feasible given the nearly 100 percent negative predictive value of the test, according to a scientific statement from the American Heart Association (AHA) published in the Aug. 17 issue of Circulation.
Using select data from 3D contrast-enhanced (CE) CT imaging can better locate areas to be ablated in patients with ventricular tachycardia, compared with standard voltage mapping, according to a small study published online July 24 in Circulation: Arrhythmia and Electrophysiology.
Researchers prospectively evaluating AdreView, GE Healthcare's iodine-123 meta-iodobenzylguanidine imaging agent, found that the agent identified symptomatic heart failure patients most likely to experience cardiac events, according to the ADMIRE-HF trial published in the May 18 issue of the Journal of the American College of Cardiology.
GE Healthcare and CardioDx, a cardiovascular genomic diagnostics company, have entered into a strategic alliance to co-develop diagnostic technologies to improve the care and management of patients with cardiovascular disease.
Written by Kaitlyn Dmyterko
Infarct size measured by MRI can be used as a predictor of ventricular tachycardia and may answer whether or not high-risk patients with an ejection fraction under 35 percent should be implanted with implantable cardioverter-defibrillators (ICDs), said Jeffrey J. Goldberger, MD, from Northwest Memorial Hospital in Chicago, during a presentation at ACC.10 in Atlanta March 15.
The FDA has approved Stereotaxis’ Celsius RMT ThermoCool for use with the company’s magnetic navigation system for the treatment of type 1 atrial flutter.
Image quality of multi-detector CT scans, when utilized for the noninvasive detection of coronary artery stenosis, can be significantly associated with patient characteristics, including ethnicity, body mass index, heart rate and the presence of breathing artifact, but not with coronary artery calcium (CAC) score at a patient level, based on a study in the January issue of the American Journal of Roentgenology.
Research presented at the 2009 American Heart Association (AHA) scientific sessions in Orlando based on the subanalysis from the ADMIRE-HF phase III clinical trial suggested that imaging of the cardiac sympathetic nerves using the molecular imaging agent 123I-meta-iodobenzylguanidine (123I-MIBG, AdreView; GE Healthcare) may be useful in the assessment of risk for cardiac arrhythmias and cardiac death.
The FDA has cleared for marketing Biosense Webster’s Carto 3 system, its 3D imaging technology, for use by electrophysiologists (EP) in treating cardiac arrhythmias.
CardioComm Solutions has shipped its Global ECG Management System (GEMS) software as part of a multi-year North American licensing agreement with GE Healthcare, and a subsequent OEM agreement.
The use of a 3D inversion recovery gradient-recalled echo sequence at 3T MRI allows accurate assessment of myocardial infarction without loss of contrast-to-noise ratio compared with a standard 2D technique, according to research published this month in the American Journal of Roentgenology.
BOSTON--In the MRI environment under specific guidelines, a new pacemaker system facilitates access to this diagnostic imaging technique with no evidence of clinical (bradycardia or tachycardia), subclinical (pacemaker performance) or technical (pacemaker or lead damage) deficits in patients, according to a late-breaking clinical pivotal trial presented May 14 at the 2009 meeting of the Heart Rhythm Society (HRS).
Wednesday, April 08 2009
CardioNet, a wireless medical technology company for the diagnosis and monitoring of cardiac arrhythmias, has acquired Biotel for approximately $14 million, expanding its portfolio to include cardiac clinical research services.
Watson Pharmaceuticals announced that one lot of 100-count bottles of Propafenone HCL 225 mg tablets, a drug used to treat cardiac arrhythmias, is being voluntarily recalled in the U.S. at the consumer level as a precautionary measure.
The FDA has approved Biosense Webster's Navistar RMT ThermoCool catheter for use in operations to eliminate abnormal heart rhythms.
Royal Philips Electronics has entered into an agreement with Bard Electrophysiology, a division of C. R. Bard, to co-develop new clinical tools to aid in treating cardiac arrhythmia disorders.
Royal Philips Electronics and Hansen Medical have agreed to co-develop integrated products that may simplify cardiac procedures to diagnose and treat cardiac arrhythmias.
Royal Philips Electronics has signed a new memorandum of understanding for a five-year cardiovascular imaging research collaboration with King’s College London.
|